Tuberculosis  >>  Sutezolid (PNU-100480)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Sutezolid (PNU-100480) / Sequella
NCT00871949: Safety, Tolerability And Pharmacokinetics Study Of Single Doses Of PNU-100480 In Healthy Adults

Completed
1
19
US
PNU-100480, Period 2, Period 3, Placebo, Period 1, Period 4 (Fed)
Sequella, Inc.
Tuberculosis
08/09
08/09
NCT00990990: Safety, Tolerability, Pharmacokinetics And Measurement Of Whole Blood Activity (WBA) Of PNU-100480 After Multiple Oral Doses In Healthy Adult Volunteers

Completed
1
59
US
PNU-100480, Placebo, Linezolid
Sequella, Inc.
Tuberculosis
05/10
05/10
NCT03199313: Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Sutezolid

Completed
1
32
US
Sutezolid, PNU-100480, Placebo, Placebo Oral Tablet
Global Alliance for TB Drug Development
Tuberculosis, Tuberculosis, Pulmonary
12/17
12/17

Download Options